Development of copper based drugs, radiopharmaceuticals and medical materials

Abstract

Copper is one of the most interesting elements for various biomedical applications. Copper compounds show vast array of biological actions, including anti-inflammatory, anti-proliferative, biocidal and other. It also offers a selection of radioisotopes, suitable for nuclear imaging and radiotherapy. Quick progress in nanotechnology opened new possibilities for design of copper based drugs and medical materials. To date, copper has not found many uses in medicine, but number of ongoing research, as well as preclinical and clinical studies, will most likely lead to many novel applications of copper in the near future.

DOI: 10.1007/s10534-012-9578-y

Extracted Key Phrases

7 Figures and Tables

01020201520162017
Citations per Year

Citation Velocity: 9

Averaging 9 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@inproceedings{Szymaski2012DevelopmentOC, title={Development of copper based drugs, radiopharmaceuticals and medical materials}, author={Paweł Szymański and Tomasz Frączek and Magdalena Markowicz and Elżbieta Mikiciuk-Olasik}, booktitle={BioMetals}, year={2012} }